BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Protalex, Inc. 



Albuquerque  New Mexico  87190  U.S.A.
Phone: 505-260-1726 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Protalex, Inc. (PRTX) To Present At Rodman & Renshaw Annual Global Investment Conference 9/5/2014 12:15:10 PM
Protalex, Inc. (PRTX) Announces Acceptance Of Abstract Highlighting Findings From U.S. Phase 1(B) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients At The 2014 American College of Rheumatology Annual Meeting 9/3/2014 9:01:22 AM
Protalex, Inc. (PRTX) Announces Data from U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients Presented At The 2014 EULAR Annual European Congress of Rheumatology 6/13/2014 7:56:52 AM
Protalex, Inc. (PRTX) Announces Preliminary Unblinded Findings From Cohorts 1-4 Of U.S. Phase 1b Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 6/3/2014 9:34:36 AM
Protalex, Inc. (PRTX) To Present Findings From U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients At The 2014 EULAR Annual European Congress Of Rheumatology 5/15/2014 8:54:32 AM
Protalex, Inc. (PRTX) Adds Three Industry Leaders To Clinical Development Team 5/5/2014 6:55:17 AM
Protalex, Inc. (PRTX) Announces Interim Findings From U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 2/10/2014 8:10:51 AM
Protalex, Inc. (PRTX) Announces Appointment Of Marco M. Elser To Its Board Of Directors 2/5/2014 7:58:13 AM
Protalex, Inc. (PRTX) Announces Completion Of $2.8 Million Private Placement 1/23/2014 9:27:36 AM
Protalex, Inc. (PRTX) Initiates Enrollment of Final Cohort in Phase 1b Trial of PRTX-100 in Active Rheumatoid Arthritis Patients 10/31/2013 12:16:59 PM
123456